NS Investment (NSI) is an affiliated firm of Dong-A ST, a leading pharmaceutical company.
NS Investment (NSI) is an affiliated firm of Dong-A ST, a leading pharmaceutical company in the Republic of Korea. NSI was established in 2015 to independently manage venture capital funds and serve institutional investors in Korea. NSI is focused on meeting the financial objective of its fund investors. NSI seeks to link Korean investor capital with innovative companies beyond its domestic boarders and ultimately link entrepreneurs and science across continents.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 9, 2022
![]() |
Series B | $147.50M | Biotechnology | — |
Oct 21, 2021
![]() |
Series B | $210M | Biopharma | — |
Feb 21, 2018
![]() |
Series C | $50M | Biotechnology | — |